Pharma manufacturing continues to come under pressure in India as the country passes the half-way mark in a 21-day, country-wide lock-down enforced as part of measures to contain the spread of COVID-19.
While the pharma industry and Indian government are working in close co-ordination to address the challenges, top companies have provided...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

